# IMKELDI

NDC: 81927-201
Generic name: imatinib oral
Labeler / Manufacturer: Shorla Oncology Inc.,
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: ORAL
Marketing started: 20241219

FDA application: NDA219097

## Active ingredients

- IMATINIB MESYLATE: 80 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"81927-201"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=81927-201
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=26658bb7-9ba1-a10e-e063-6394a90a172e